Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Foster

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Circulation Research|March 29, 2011
Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formationJing Li, Richard M Cubbon, Lesley A Wilson, et al.
Circulation Research|September 27, 2022
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial HypertensionBastien Masson, Hélène Le Ribeuz, Jessica Sabourin, et al.
Communications Medicine|April 19, 2025
Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathiesClaire E L Smith, Andrew J Streets, Alice V R Lake, et al.
British Journal of Pharmacology|December 2, 2022
Improved PIEZO1 agonism through 4-benzoic acid modification of Yoda1Gregory Parsonage, Kevin Cuthbertson, Naima Endesh, et al.
Nature Medicine|February 3, 2026
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trialRichard S Finkel, Thomas O Crawford, Eugenio Mercuri, et al.
Nature Medicine|April 23, 2026
Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trialRichard S Finkel, Thomas O Crawford, Eugenio Mercuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Active surveillance is the preferred approach to clinical stage I testicular cancerCraig R Nichols, Bruce Roth, Peter Albers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2015
Orai3 Surface Accumulation and Calcium Entry Evoked by Vascular Endothelial Growth FactorJing Li, Alexander-Francisco Bruns, Bing Hou, et al.
The Journal of Biological Chemistry|March 23, 2017
Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channelsHussein N Rubaiy, Melanie J Ludlow, Matthias Henrot, et al.
Elife|November 10, 2020
Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapyJoseph Shaw, Rajendra Gosain, Monoj Mon Kalita, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Circulation Research|March 29, 2011
Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formationJing Li, Richard M Cubbon, Lesley A Wilson, et al.
Circulation Research|September 27, 2022
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial HypertensionBastien Masson, Hélène Le Ribeuz, Jessica Sabourin, et al.
Communications Medicine|April 19, 2025
Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathiesClaire E L Smith, Andrew J Streets, Alice V R Lake, et al.
British Journal of Pharmacology|December 2, 2022
Improved PIEZO1 agonism through 4-benzoic acid modification of Yoda1Gregory Parsonage, Kevin Cuthbertson, Naima Endesh, et al.
Nature Medicine|February 3, 2026
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trialRichard S Finkel, Thomas O Crawford, Eugenio Mercuri, et al.
Nature Medicine|April 23, 2026
Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trialRichard S Finkel, Thomas O Crawford, Eugenio Mercuri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Active surveillance is the preferred approach to clinical stage I testicular cancerCraig R Nichols, Bruce Roth, Peter Albers, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 11, 2015
Orai3 Surface Accumulation and Calcium Entry Evoked by Vascular Endothelial Growth FactorJing Li, Alexander-Francisco Bruns, Bing Hou, et al.
The Journal of Biological Chemistry|March 23, 2017
Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channelsHussein N Rubaiy, Melanie J Ludlow, Matthias Henrot, et al.
Elife|November 10, 2020
Rationally derived inhibitors of hepatitis C virus (HCV) p7 channel activity reveal prospect for bimodal antiviral therapyJoseph Shaw, Rajendra Gosain, Monoj Mon Kalita, et al.
Pageof 11